AbbVie (ABBV) Revenue — Quarter Ended Sep 30, 2023
Revenue for the quarter was essentially flat compared to the immediately preceding quarter. Compared to the same quarter one year earlier, revenue declined.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue for the quarter was essentially flat compared to the immediately preceding quarter. Compared to the same quarter one year earlier, revenue declined.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$13.9B
Revenue reported for this quarter.
Quarter-over-quarter
+0.4%
Change from the immediately preceding quarter.
Year-over-year
-6.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$55.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $15.1B | +1.6% |
| Mar 31, 2023 | $12.2B | -9.7% |
| Jun 30, 2023 | $13.9B | -4.9% |
| Sep 30, 2023 | $13.9B | -6.0% |
Revenue performance
The reported revenue direction is slightly positive on a sequential basis but negative year over year.
Quarterly comparison
Revenue increased modestly from the prior quarter, reversing a decline seen in the previous sequential period. However, revenue was lower than the same quarter a year ago, continuing a year-over-year downward trend.
What to watch
Monitor whether the sequential stabilization can sustain or if year-over-year pressure persists in coming quarters.